Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

1.

Elevated vancomycin trough is not associated with nephrotoxicity among inpatient veterans.

Prabaker KK, Tran TP, Pratummas T, Goetz MB, Graber CJ.

J Hosp Med. 2012 Feb;7(2):91-7. doi: 10.1002/jhm.946. Epub 2011 Nov 15.

PMID:
22086511
[PubMed - indexed for MEDLINE]
2.

The Relationship of nephrotoxicity to vancomycin trough serum concentrations in a veteran's population: a retrospective analysis.

Horey A, Mergenhagen KA, Mattappallil A.

Ann Pharmacother. 2012 Nov;46(11):1477-83. doi: 10.1345/aph.1R158. Epub 2012 Oct 16.

PMID:
23073306
[PubMed - indexed for MEDLINE]
3.

Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.

Cano EL, Haque NZ, Welch VL, Cely CM, Peyrani P, Scerpella EG, Ford KD, Zervos MJ, Ramirez JA, Kett DH; Improving Medicine through Pathway Assessment of Critical Therapy of Hospital-Acquired Pneumonia (IMPACT-HAP) Study Group.

Clin Ther. 2012 Jan;34(1):149-57. doi: 10.1016/j.clinthera.2011.12.013.

PMID:
22284995
[PubMed - indexed for MEDLINE]
4.

Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.

Lodise TP, Patel N, Lomaestro BM, Rodvold KA, Drusano GL.

Clin Infect Dis. 2009 Aug 15;49(4):507-14. doi: 10.1086/600884.

PMID:
19586413
[PubMed - indexed for MEDLINE]
Free Article
5.

Effects of targeting higher vancomycin trough levels on clinical outcomes and costs in a matched patient cohort.

Kullar R, Davis SL, Taylor TN, Kaye KS, Rybak MJ.

Pharmacotherapy. 2012 Mar;32(3):195-201. doi: 10.1002/j.1875-9114.2011.01017.x. Erratum in: Pharmacotherapy. 2012 Sep;32(9):869.

PMID:
22392452
[PubMed - indexed for MEDLINE]
6.

Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections.

Hermsen ED, Hanson M, Sankaranarayanan J, Stoner JA, Florescu MC, Rupp ME.

Expert Opin Drug Saf. 2010 Jan;9(1):9-14. doi: 10.1517/14740330903413514.

PMID:
20021290
[PubMed - indexed for MEDLINE]
7.

Increasing vancomycin serum trough concentrations and incidence of nephrotoxicity.

Pritchard L, Baker C, Leggett J, Sehdev P, Brown A, Bayley KB.

Am J Med. 2010 Dec;123(12):1143-9. doi: 10.1016/j.amjmed.2010.07.025.

PMID:
21183005
[PubMed - indexed for MEDLINE]
8.

Identification of risk factors for nephrotoxicity in patients receiving extended-duration, high-trough vancomycin therapy.

Contreiras C, Legal M, Lau TT, Thalakada R, Shalansky S, Ensom MH.

Can J Hosp Pharm. 2014 Mar;67(2):126-32.

PMID:
24799722
[PubMed]
9.

A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.

Jeffres MN, Isakow W, Doherty JA, Micek ST, Kollef MH.

Clin Ther. 2007 Jun;29(6):1107-15.

PMID:
17692725
[PubMed - indexed for MEDLINE]
10.

Lack of vancomycin-associated nephrotoxicity in newborn infants: a case-control study.

Bhatt-Mehta V, Schumacher RE, Faix RG, Leady M, Brenner T.

Pediatrics. 1999 Apr;103(4):e48.

PMID:
10103340
[PubMed - indexed for MEDLINE]
11.

Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines.

Kullar R, Leonard SN, Davis SL, Delgado G Jr, Pogue JM, Wahby KA, Falcione B, Rybak MJ.

Pharmacotherapy. 2011 May;31(5):441-8. doi: 10.1592/phco.31.5.441.

PMID:
21923425
[PubMed - indexed for MEDLINE]
12.

Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy.

Wong-Beringer A, Joo J, Tse E, Beringer P.

Int J Antimicrob Agents. 2011 Feb;37(2):95-101. doi: 10.1016/j.ijantimicag.2010.10.013. Epub 2010 Dec 3. Review.

PMID:
21130609
[PubMed - indexed for MEDLINE]
13.

Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy.

Ingram PR, Lye DC, Tambyah PA, Goh WP, Tam VH, Fisher DA.

J Antimicrob Chemother. 2008 Jul;62(1):168-71. doi: 10.1093/jac/dkn080. Epub 2008 Mar 10.

PMID:
18334494
[PubMed - indexed for MEDLINE]
Free Article
14.

Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity.

Lodise TP, Lomaestro B, Graves J, Drusano GL.

Antimicrob Agents Chemother. 2008 Apr;52(4):1330-6. doi: 10.1128/AAC.01602-07. Epub 2008 Jan 28.

PMID:
18227177
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial.

Bosso JA, Nappi J, Rudisill C, Wellein M, Bookstaver PB, Swindler J, Mauldin PD.

Antimicrob Agents Chemother. 2011 Dec;55(12):5475-9. doi: 10.1128/AAC.00168-11. Epub 2011 Sep 26.

PMID:
21947388
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter.

van Hal SJ, Paterson DL, Lodise TP.

Antimicrob Agents Chemother. 2013 Feb;57(2):734-44. doi: 10.1128/AAC.01568-12. Epub 2012 Nov 19. Review.

PMID:
23165462
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Nephrotoxicity in patients with vancomycin trough concentrations of 15-20 μg/ml in a pediatric intensive care unit.

Cies JJ, Shankar V.

Pharmacotherapy. 2013 Apr;33(4):392-400. doi: 10.1002/phar.1227. Epub 2013 Mar 7.

PMID:
23471688
[PubMed - indexed for MEDLINE]
18.

Vancomycin-induced acute kidney injury detected by a prospective pharmacovigilance program from laboratory signals.

Ramírez E, Jiménez C, Borobia AM, Tong HY, Medrano N, Krauel-Bidwell L, Carcas AJ, Selgas R, Frías J.

Ther Drug Monit. 2013 Jun;35(3):360-6. doi: 10.1097/FTD.0b013e318286eb86.

PMID:
23666575
[PubMed - indexed for MEDLINE]
19.

A comparative assessment of vancomycin-associated nephrotoxicity in the young versus the elderly hospitalized patient.

Vance-Bryan K, Rotschafer JC, Gilliland SS, Rodvold KA, Fitzgerald CM, Guay DR.

J Antimicrob Chemother. 1994 Apr;33(4):811-21.

PMID:
8056700
[PubMed - indexed for MEDLINE]
20.

Performance of a vancomycin dosage regimen developed for obese patients.

Reynolds DC, Waite LH, Alexander DP, DeRyke CA.

Am J Health Syst Pharm. 2012 Jun 1;69(11):944-50. doi: 10.2146/ajhp110324.

PMID:
22610026
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk